Veterinary Medicines

Drontal Oral Suspension for Puppies 15/5 mg/ml

Authorised
  • Febantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
Drontal Oral Suspension for Puppies 15/5 mg/ml
DRONSTOP CHIOT 15/5 MG/ML SUSPENSION BUVABLE
Active substance:
  • Febantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Febantel
    15.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Pyrantel embonate
    14.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AF02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:
  • Material of the primary container:White high density polyethylene bottle.White polypropylene screw closure.Colourless low density polyethylene adapter insert.Container volume:100ml.Devices supplied (if relevant):5ml transparent polypropylene syringe with rubber plunger.
  • Material of the primary container:White high density polyethylene bottle.White polypropylene screw closure.Colourless low density polyethylene adapter insert.Container volume:50ml.Devices supplied (if relevant):5ml transparent polypropylene syringe with rubber plunger.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma + Veterinaer Produkte GmbH
  • Vetoquinol Biowet Sp. z o.o.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/1134599 0/2008
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0473/001
Concerned member states:
  • Austria
  • Estonia
  • Finland
  • France
  • Germany
  • Iceland
  • Latvia
  • Lithuania
  • Norway
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/01/2022
Download
French (PDF)
Published on: 24/11/2025
Download

Combined File of all Documents

English (PDF)
Published on: 16/11/2025
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 24/11/2025
Download